196-210 of 981
Analyzing Outpatient Worsening Heart Failure in ATTR-CM
Heart MattersAnalyzing Outpatient Worsening Heart Failure in ATTR-CM
Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Heart MattersCurrent and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
Ahmad Masri, MD, MS
Shared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Heart MattersShared Decision-Making in Transthyretin Amyloid Cardiomyopathy Care
Ahmad Masri, MD, MS
The Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
DermConsultThe Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
Jenny Murase, MD
Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
Project Oncology®Cardiac Complications in Sickle Cell Disease: Emerging Evidence and Risks
Parul Rai
Partnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
Perspectives with the AMAPartnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
Charles Turck, PharmD, BCPS, BCCCP
Jeff Brandes
- advertisement
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
On the Frontlines of COPDECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
Raymond Wade, MD
Scaling Success: Hypertension Control at MPCA with the AMA MAP™ Program
Perspectives with the AMAScaling Success: Hypertension Control at MPCA with the AMA MAP™ Program
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Faiyaz Syed MD, MPH
Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
On the Frontlines of PsoriasisSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Joel M. Gelfand, MD, MSCE, FAAD
Michael S. Garshick, MD
Improving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Heart MattersImproving ATTR-CM Diagnosis: Insights on Heart Failure Phenotypes
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Heart MattersEarly Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Rivaroxaban as effective as warfarin for left ventricular thrombus post-MI
ACC Action CenterRivaroxaban as effective as warfarin for left ventricular thrombus post-MI
Anna Bortnick, MD, PhD
- advertisement
Anna Bortnick, MD, PhD
Mobile integrated health program in patients with HF
ACC Action CenterMobile integrated health program in patients with HF
Ruth Masterson Creber, PhD
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
ACC Action CenterPhase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Darren K. McGuire, MD